Neuroprotection by nitrous oxide: Facts and evidence

Critical Care Medicine

Volumn 36, Issue 9, 2008, Pages 2651-2659

  Haelewyn, Benoit ^a   David, Hélène N ^a   Rouillon, Christophe ^b   Chazalviel, Laurent ^b   Lecocq, Myriam ^b   Risso, Jean Jacques ^c   Lemaire, Marc ^d   Abraini, Jacques H ^a,b  

^a NNOXe Pharmaceuticals Inc   (Canada)

^b UNIVERSITÉ DE CAEN   (France)

^c Military Teaching Hospital Sainte Anne   (France)

^d AIR LIQUIDE   (France)

Author keywords

Brain ischemia; N methyl D aspartate (NMDA) neurotoxicity; Nitrous oxide; Oxygen glucose deprivation; Therapeutic window of opportunity

Indexed keywords

NITROUS OXIDE; DOPAMINE; GLUCOSE; LACTATE DEHYDROGENASE; N METHYLASPARTIC ACID; NEUROPROTECTIVE AGENT; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN DAMAGE; BRAIN ISCHEMIA; CELL DAMAGE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; EXCITOTOXICITY; HISTOLOGY; MALE; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BODY TEMPERATURE; BRAIN; CEREBRAL ARTERY DISEASE; IN VITRO STUDY; METABOLISM; MOTOR ACTIVITY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BODY TEMPERATURE; BRAIN; BRAIN ISCHEMIA; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; INFARCTION, MIDDLE CEREBRAL ARTERY; L-LACTATE DEHYDROGENASE; MALE; MOTOR ACTIVITY; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; NITROUS OXIDE; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 53049085175     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318183f646     Document Type: Article

References (47)

1. Parsons CG, Danysz W, Quack G: Glutamate in CNS disorders as a target for drug development: An update. Drug News Perspect 1998; 11:523-569
2. Endres M, Dirnagl U: Ischemia and stroke. Adv Exp Med Biol 2002; 513:455-473
3. Olney JW, Labruyere J, Price MT: Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989; 244:1360-1362
4. Olney JW, Labruyere J, Wang G, et al: NMDA antagonist neurotoxicity mechanism and prevention. Science 1991; 254:1515-1518
5. Davis SM, Lees KR, Albers GW, et al: Selfotel in acute ischemic stroke: Possible neurotoxic effects of an NMDA antagonist. Stroke 2000; 31:347-354
6. David HN, Leveillé F, Chazalviel L, et al: Reduction of ischemic brain damage by nitrous oxide and xenon. J Cereb Blood Flow Metab 2003; 23:1168-1173
7. Homi HM, Yokoo N, Warner DS, et al: The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology 2003; 99: 876-881
8. Ma D, Yang H, Lynch J, et al: Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat. Anesthesiology 2003; 98:690-698
9. Ma D, Hossain M, Chow A, et al: Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 2005; 58:182-193
10. Dingley J, Tooley J, Porter H, et al: Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxiaischemia. Stroke 2006; 37:501-506
11. Abraini JH, Lemaire M, David HN: Potentially neuroprotective and therapeutic properties of nitrous oxide and xenon. Ann NY Acad Sci 2005; 1053:289-300
12. David HN, Haelewyn B, Rouillon C, et al: Dose-response neuroprotective effects of xenon and therapeutic window of opportunity in rats subjected to transient focal cerebral ischemia. FASEB J 2008; 22:1275-1286
13. Jevtovic-Todorovic V, Todorovic SM, Mennerick S, et al: Nitrous oxide is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med 1998; 4:460-463
14. David HN, Ansseau M, Lemaire M, et al: Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization. Biol Psychiatry 2006; 60:49-57
15. Yamakura T, Harris RA: Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol. Anesthesiology 2000; 93:1095-1101
16. Dinse A, Fohr KJ, Georgieff M, et al: Xenon reduces glutamate-, AMPA-, and kainateinduced membrane currents in cortical neurones. Br J Anaesth 2005; 94:479-485
17. Gruss M, Bushell TJ, Bright DP, et al: Twopore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 2004; 65: 443-452
18. Colloc'h N, Sopkoya-de Oliveira Santos J, Retailleau P, et al: Protein crystallography under xenon and nitrous oxide pressure: Comparison with in vivo pharmacology studies and implications for the mechanism of inhaled anesthetic action. Biophys J 2007; 92: 217-224
19. Nagata A, Nakao Si S, Nishizawa N, et al: Xenon inhibits but N(2)O enhances ketamine induced c-fos expression in the rat posterior cingulated and retrosplenial cortices. Anesth Analg 2001; 92:362-368
20. Mullenix PJ, Moore PA, Tassinari MS: Behavioral toxicity of nitrous oxide in rats following prenatal exposure. Toxicol Ind Health 1986; 2:273-287
21. Jevtovic-Todorovic V, Beals J, Benshoff N, et al: Prolonged exposure to inhalational anesthetic nitrous oxide kills neurons in adult rat brain. Neuroscience 2003; 122:609-616
22. Jevtovic-Todorovic V, Carter LB: The anesthetics nitrous oxide and ketamine are more neurotoxic to old than to young rat brain. Neurobiol Aging 2005; 26:947-956
23. Ma D, Williamson P, Januszewski A, et al: Xenon mitigates isoflurane-induced neuronal apoptosis in the developing rodent brain. Anesthesiology 2007; 106:746-753
24. Yokoo N, Sheng H, Mixco J, et al: Intraischemic nitrous oxide alters neither neurologic nor histologic outcome: A comparison with dizocilpine. Anesth Analg 2004; 99:896-903
25. Louis-Ferdinand RT: Myelotoxic, neurotoxic and reproductive adverse effects of nitrous oxide. Adv Drug React Toxicol Rev 1994; 13:193-206
26. Weimann J: Toxicity of nitrous oxide. Best Pract Res Clin Anaesthesiol 2003; 17:47-61
27. Lin CY, Guo WY, Chen SP, et al: Neurotoxicity of nitrous oxide: Multimodal evoked potentials in an abuser. Clin Toxicol (Phila) 2007; 45:67-71
28. Dyck PJ, Grina LA, Lambert EH, et al: Nitrous oxide neurotoxicity studies in man and rat. Anesthesiology 1980; 53:205-209
29. Smith I: Nitrous oxide in ambulatory anesthesia: Does it have a place in day surgical anesthesia or is it just a threat for personnel and the global environment? Curr Opin Anesthesiol 2006; 19:592-596
30. Hopkins PM: Nitrous oxide: A unique drug of continuing importance for anaesthesia. Best Pract Res Clin Anaesthesiol 2005; 19: 381-389
31. Monyer H, Golberg MP, Choi DS: Glucose deprivation neuronal injury in cortical cell culture. Brain Res 1989; 483:347-354
32. Priestley T, Horne AL, McKernan RM, et al: The effect of NMDA receptor glycine site antagonists on hypoxia-induced neurodegeneration of rat cortical cell cultures. Brain Res 1990; 531:183-188
33. Koh JY, Choi DW: Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods 1987; 20:83-90
34. White PF, Johnston RR, Eger EI 2nd: Determination of anesthetic requirement in rats. Anesthesiology 1974; 40:52-57
35. Kollmar R, Blank T, Han JL, et al: Different degrees of hypothermia after experimental stroke: Short- and long-term outcome. Stroke 2007; 38:1585-1589
36. Zhou M, Baudry M: Developmental changes in NMDA neurotoxicity reflect changes in subunit composition of N-methyl-D-aspartate (NMDA) receptors. J Neurosci 2006; 26: 2956-2963
37. McCarran WJ, Goldberg MP: White matter axon vulnerability to AMPA/Kainate receptor-mediated ischemic injury is developmentally regulated. J Neurosci 2007; 27: 4220-4229
38. Tyson GW, Teadsale GM, Graham DI, et al: Focal cerebral ischemia in the rat: Topography of hemodynamic and histopathological changes. Ann Neurol 1984; 15:559-567
39. Fisher CM: Lacunes: Small, deep cerebral infarcts - 1965. Neurology 1998; 50:841-852
40. Abraini JH, David HN, MacKenzie ET, et al: Postischemic nitrous oxide alone versus intraischemic nitrous oxide in the presence of isoflurane: What it may change for neuropro tection against cerebral stroke in the rat. Anesth Analg 2005; 101:614
41. Marota JJ, Mandeville JB, Liu CH: Acute tolerance develops to the cerebrovascular effects of nitrous oxide. J Neurosurg Anesthesiol 2007; 19:291;(Abstract no.9)
42. Sugaya T, Kitani Y: Nitrous oxide attenuates the protective effect of isoflurane on microtubule-associated protein2 degradation during forebrain ischemia in the rat. Brain Res Bull 1997; 44:307-309
43. Goto T, Nakata Y, Ishiguro Y, et al: Minimum alveolar concentration-awake of xenon alone and in combination with isoflurane or sevoflurane. Anesthesiology 2000; 93:1188-1193
44. Gyulai FE, Firestone LL, Mintun MA, et al: In vivo imaging of limbic responses to nitrous oxide inhalation. Anesth Analg 1996; 83: 291-298
45. Lorenz UH, Kolbitsch C, Hinteregger M, et al: Remifentanil and nitrous oxide reduce changes in cerebral blood flow velocity in the middle cerebral artery caused by pain. Br J Anaesth 2003; 90:296-299
46. Henninger N, Kuppers-Tiedt L, Sicard KM, et al: Neuroprotective effect of hyperbaric oxygen therapy monitored by MR-imaging after embolic stroke in rats. Exp Neurol 2006; 201:316-323
47. Haelewyn B, Alix P, Maubert E, et al: Timecourse of NMDA-induced striatal brain damage in rats and time-dependence reliability of thionin staining. J Neurosci Methods 2008; 168:479-482